IOVS Stroke
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Aihara, M.
Right arrow Articles by Weinreb, R. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Aihara, M.
Right arrow Articles by Weinreb, R. N.
(Investigative Ophthalmology and Visual Science. 2001;42:2554-2559.)
© 2001 by The Association for Research in Vision and Ophthalmology, Inc.

Enhanced FGF-2 Movement through Human Sclera after Exposure to Latanoprost

Makoto Aihara, James D. Lindsey and Robert N. Weinreb

From the Glaucoma Center, University of California San Diego, La Jolla.

PURPOSE. To determine whether exposure of sclera to latanoprost acid alters transscleral permeation by FGF-2.

METHODS. Pieces of human sclera were isolated from donor eyes after death, placed in organ culture, and exposed to 50 to 200 nM latanoprost acid or vehicle for 3 days. Transscleral permeability was then assessed by placing each scleral piece into a Ussing apparatus and measuring the amount of FGF-2 that moves from the orbital side to the uveal side of the scleral piece. Transscleral permeation by 10-kDa tetramethylrhodamine-dextran also was determined, for comparison.

RESULTS. Transscleral permeation by FGF-2 through sclera that had been incubated with vehicle was 1.53 ± 0.86 x 10-8 cm/sec. Transscleral permeation by 10-kDa tetramethylrhodamine-dextran was 1.04 ± 0.39 x 10-6 cm/sec. FGF-2 permeation of sclera exposed to 50, 100, and 200 nM latanoprost acid was increased by an average of 48% ± 62%, 100% ± 108%, and 108% ± 79%, respectively, compared with sclera exposed to vehicle (n = 13; P < 0.05). Scleral permeation by 10-kDa dextran after exposure to 50, 100, or 200 nM latanoprost acid was significantly increased by 42% ± 36%, 59% ± 51%, and 65% ± 49%, respectively (n = 14; P < 0.05). The ratio of dextran to FGF-2 permeation was approximately 90 and did not vary with 50, 100, or 200 nM latanoprost acid (P = 0.93, ANOVA).

CONCLUSIONS. Exposure of sclera to latanoprost acid increases transscleral permeation by FGF-2 in human scleral organ cultures. Because this increase parallels the increased scleral permeability caused by dextran, it may reflect a general enhancement of permeability, a possibility that future in vivo studies should explore.




This article has been cited by other articles:


Home page
 IOVSHome page
K. Okabe, H. Kimura, J. Okabe, A. Kato, H. Shimizu, T. Ueda, S. Shimada, and Y. Ogura
Effect of Benzalkonium Chloride on Transscleral Drug Delivery
Invest. Ophthalmol. Vis. Sci., February 1, 2005; 46(2): 703 - 708.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
M. Aihara, J. D. Lindsey, and R. N. Weinreb
Ocular Hypertension in Mice with a Targeted Type I Collagen Mutation
Invest. Ophthalmol. Vis. Sci., April 1, 2003; 44(4): 1581 - 1585.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
T. W. Kim, J. D. Lindsey, M. Aihara, T. L. Anthony, and R. N. Weinreb
Intraocular Distribution of 70-kDa Dextran after Subconjunctival Injection in Mice
Invest. Ophthalmol. Vis. Sci., June 1, 2002; 43(6): 1809 - 1816.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the Association for Research in Vision and Ophthalmology